Skip to search formSkip to main contentSkip to account menu

Brainstem activation specific to migraine headache

View on Elsevier (opens in a new tab)

A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate.

Results suggest that lateralization of pain in migraine is due to lateralized brain dysfunction, and the activation persisted after pain was controlled by sumatriptan.
View on PubMed (opens in a new tab)

Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study.

The activation pattern in the dorsal rostral pons is highly suggestive of a role for this structure in the pathophysiology of chronic migraine and the localization and persistence of activity during stimulation is exactly consistent with a region activated in episodic migraine, and with the persistence of activation of that area after successful treatment.
View on PubMed (opens in a new tab)

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Galcanezumab 120 or 240 mg given once monthly was efficacious, safe, and well tolerated and both doses were superior to placebo for all key secondary endpoints.
View on SAGE (opens in a new tab)

Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA.

A new set of diagnostic criteria for these syndromes is proposed to better encompass the clinical presentations and which include a wider range of attack length, wider trigeminal pain distribution, cutaneous triggering and lack of refractory period.
View on PubMed (opens in a new tab)

The clinical characteristics of headache in patients with pituitary tumours.

Headache appears to be a significant problem in pituitary disease and is associated with a range of headache phenotypes, likely to be governed by a combination of factors, including tumour activity, relationship to the cavernous sinus and patient predisposition to headache.
View on PubMed (opens in a new tab)

Clinical Presentation, Investigation Findings, and Treatment Outcomes of Spontaneous Intracranial Hypotension Syndrome

This systematic review and meta-analysis provides an objective summary of the available evidence on the clinical presentation, investigations findings, and treatment outcomes for spontaneous…
View on PubMed (opens in a new tab)

Subcutaneous octreotide in cluster headache: Randomized placebo‐controlled double‐blind crossover study

Subcutaneous octreotide 100μg is effective in the acute treatment of cluster headache when compared with placebo and nonvasconstrictor treatment of acute cluster headache is possible.
View on Wiley (opens in a new tab)

Posterior hypothalamic activation in paroxysmal hemicrania

The purpose of the study was to determine the brain structures active in paroxysmal hemicrania.
View on Wiley (opens in a new tab)

Paroxysmal hemicrania: a prospective clinical study of 31 cases.

The International Headache Society criteria for paroxysmal hemicrania should be revised to remove specification of attack site, and to include the full range of cranial autonomic features.
View on PubMed (opens in a new tab)
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)